Annual Shareholders Equity
$466.99 M
+$64.15 M+15.93%
December 31, 2023
Summary
- As of February 7, 2025, HRMY annual stockholders equity is $466.99 million, with the most recent change of +$64.15 million (+15.93%) on December 31, 2023.
- During the last 3 years, HRMY annual shareholders equity has risen by +$369.81 million (+380.54%).
- HRMY annual shareholders equity is now at all-time high.
Performance
HRMY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$596.80 M
+$58.22 M+10.81%
September 30, 2024
Summary
- As of February 7, 2025, HRMY quarterly stockholders equity is $596.80 million, with the most recent change of +$58.22 million (+10.81%) on September 30, 2024.
- Over the past year, HRMY quarterly shareholders equity has increased by +$129.81 million (+27.80%).
- HRMY quarterly shareholders equity is now at all-time high.
Performance
HRMY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
HRMY Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +15.9% | +27.8% |
3 y3 years | +380.5% | +292.6% |
5 y5 years | +472.8% | - |
HRMY Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +150.4% | at high | +220.0% |
5 y | 5-year | at high | +4131.0% | at high | +1301.1% |
alltime | all time | at high | +4131.0% | at high | +1301.1% |
Harmony Biosciences Holdings Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $596.80 M(+10.8%) |
Jun 2024 | - | $538.58 M(+4.5%) |
Mar 2024 | - | $515.39 M(+10.4%) |
Dec 2023 | $466.99 M(+15.9%) | $466.99 M(-3.0%) |
Sep 2023 | - | $481.33 M(-0.8%) |
Jun 2023 | - | $485.17 M(+9.5%) |
Mar 2023 | - | $443.04 M(+10.0%) |
Dec 2022 | $402.84 M | $402.84 M(+17.1%) |
Sep 2022 | - | $343.88 M(+39.5%) |
Jun 2022 | - | $246.53 M(+14.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $214.50 M(+15.0%) |
Dec 2021 | $186.51 M(+91.9%) | $186.51 M(+22.7%) |
Sep 2021 | - | $152.02 M(+20.1%) |
Jun 2021 | - | $126.55 M(+17.3%) |
Mar 2021 | - | $107.88 M(+11.0%) |
Dec 2020 | $97.18 M(-938.8%) | $97.18 M(+2.8%) |
Sep 2020 | - | $94.55 M(-291.6%) |
Jun 2020 | - | -$49.35 M(-0.7%) |
Mar 2020 | - | -$49.69 M(+328.9%) |
Dec 2019 | -$11.59 M(-114.2%) | -$11.59 M |
Dec 2018 | $81.53 M | - |
FAQ
- What is Harmony Biosciences Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual shareholders equity year-on-year change?
- What is Harmony Biosciences Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly shareholders equity year-on-year change?
What is Harmony Biosciences Holdings annual stockholders equity?
The current annual shareholders equity of HRMY is $466.99 M
What is the all time high annual shareholders equity for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual stockholders equity is $466.99 M
What is Harmony Biosciences Holdings annual shareholders equity year-on-year change?
Over the past year, HRMY annual stockholders equity has changed by +$64.15 M (+15.93%)
What is Harmony Biosciences Holdings quarterly stockholders equity?
The current quarterly shareholders equity of HRMY is $596.80 M
What is the all time high quarterly shareholders equity for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly stockholders equity is $596.80 M
What is Harmony Biosciences Holdings quarterly shareholders equity year-on-year change?
Over the past year, HRMY quarterly stockholders equity has changed by +$129.81 M (+27.80%)